Ambient clinical documentation, often called the AI scribe, is software that listens to a clinical conversation in real time, transcribes it, and drafts the visit note in the structure the chart expects. Under the hood it chains three components: automatic speech recognition (ASR) turns the audio into text, speaker diarization tags who said what, and a large language model (LLM) — software trained to generate fluent text — composes a draft note from that transcript. The point is to give the clinician minutes back per visit by removing manual typing, while keeping a human in the loop: the clinician reviews and signs every note before it enters the record.
For a telemedicine video team this is usually the highest-return AI feature, but it is also the one that touches the most sensitive data. The audio, the transcript, and the draft note are all protected health information (PHI) under HIPAA. That means every vendor in the path — the ASR provider, the LLM provider, any cloud processor — must sign a Business Associate Agreement (BAA), and you must be able to show where that PHI is processed and stored. The HIPAA Security Rule (45 CFR Part 164, Subpart C) governs the access controls, audit logging, and encryption around it.
The regulatory line to watch is the FDA's Software as a Medical Device (SaMD) boundary. As long as the output is documentation that a clinician edits and signs, it stays on the documentation side. If the tool starts asserting diagnoses or recommending treatment on its own, it can cross into regulated medical-device territory. The common pitfall is trusting the draft: LLMs can hallucinate — invent plausible-sounding content — so a note that fabricates a symptom or dosage is a real clinical and legal risk. The sign-off step is not a formality; it is the safety control.
